Zoekresultaten - 8 results
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
3 months (but more than 2 weeks ago), the prevalence of anti- SARS-CoV-2 antibodies was 97.9% in the first period of wave 2 (27/09-24/10) and 99.1% in the second period (25/10-21/11). Among the fully ...
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
chronic disease (OR a 0.22 (95% CI 0.08–0.62)), having received an mRNA-type vaccine (OR a 5.38 (95% CI 1.72–16.80)), and having received an influenza vaccine in 2020–2021 (OR a 3.79 (95% CI 1.30–11.07)). ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
community dwelling population aged 18 years and above had developed anti- SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% ...
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
Jane Idavain; Tina Lesnik; Elena Von der Lippe; Marek Majdan; Milena Santric-Milicevic; Elena Pallari; José L. Peñalvo; Sara M. Pires; Dietrich Plaß; João V. Santos; Diane L. Stockton; Sofie Theresa ...
Valuing the years of life lost due to COVID-19: the differences and pitfalls
Publication Type: Peer reviewed scientific article Authors: Brecht Devleesschauwer; Scott A McDonald; Niko Speybroeck; Grant M. A. Wyper Source: International Journal of Public Health, Volume 65, ...
RESISTIRE D3.3 Summary report on mapping quantitative indicators- cycle 3
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Audrey Harroche; Alexis Still; Charikleia Tzanakou; Federica Rossetti; Lorenzo Lionello; Rana Charafeddine ...
L’épidémiologie de l’affection post-Covid-19 en Belgique
participants (n = 2.092) déclaraient avoir au moins un symptôme lié à leur infection au SARS-CoV-2 trois mois après celle-ci, mais sans nécessairement toujours déclarer un moins bon état de santé. Environ 30% ...
De epidemiologie van long covid in België
twee jaar (april 2021 — april 2023), uitgevoerd bij volwassenen die een SARS-CoV-2-infectie hadden opgelopen. 47% van de patiënten (n = 2.092) gaf aan dat ze drie maanden na de SARS-CoV-2-infectie nog ...